Lak Asad M, Rahimi Amina, Abunimer Abdullah M, Tafel Ian, Devi Sharmila, Premkumar Akash, Ida Fidelia, Lu Yi, Chi John H, Tanguturi Shyam, Groff Michael W, Zaidi Hasan A
1Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2Faculty of Life Sciences and Medicine, King's College, London, United Kingdom.
J Neurosurg Spine. 2020 Apr 3;33(2):237-244. doi: 10.3171/2020.1.SPINE191326. Print 2020 Aug 1.
Metastatic spinal cord compression (MSCC) imposes significant impairment on patient quality of life and often requires immediate surgical intervention. In this study the authors sought to estimate the impact of surgical intervention on patient quality of life in the form of mean quality-adjusted life years (QALY) gained and identify factors associated with positive outcomes.
The authors performed a retrospective chart review and collected data for patients who had neurological symptoms resulting from radiologically and histologically confirmed MSCC and were treated with surgical decompression during the last 12 years.
A total of 151 patients were included in this study (mean age 60.4 years, 57.6% males). The 5 most common metastatic tumor types were lung, multiple myeloma, renal, breast, and prostate cancer. The majority of patients had radioresistant tumors (82.7%) and had an active primary site at presentation (67.5%). The median time from tumor diagnosis to cord compression was 12 months and the median time from identification of cord compression to death was 4 months. Preoperative presenting symptoms included motor weakness (70.8%), pain (70.1%), sensory disturbances (47.6%), and bowel or bladder disturbance (31.1%). The median estimated blood loss was 500 mL and the average length of hospital stay was 10.3 days. About 18% of patients had postoperative complications and the mean follow-up was 7 months. The mean pre- and postoperative ECOG (Eastern Cooperative Oncology Group) performance status grades were 3.2 and 2.4, respectively. At follow-up, 58.3% of patients had improved status, 31.5% had no improvement, and 10.0% had worsening of functional status. The mean QALY gained per year in the entire cohort was 0.55. The mean QALY gained in the first 6 months was 0.1 and in the first year was 0.4. For patients who lived 1-2, 2-3, 3-4, or 4-5 years, the mean QALY gained were 0.8, 1.4, 1.7, and 2.3, respectively. Preoperative motor weakness, bowel dysfunction, bladder dysfunction, and ASA (American Society of Anesthesiologists) class were identified as independent predictors inversely associated with good outcome.
The mean QALY gained from surgical decompression in the first 6 months and first year equals 1.2 months and 5 months of life in perfect health, respectively. These findings suggest that surgery might also be beneficial to patients with life expectancy < 6 months.
转移性脊髓压迫症(MSCC)严重损害患者生活质量,通常需要立即进行手术干预。在本研究中,作者试图评估手术干预对患者生活质量的影响,以获得的平均质量调整生命年(QALY)来衡量,并确定与良好预后相关的因素。
作者进行了一项回顾性病历审查,收集了过去12年中因放射学和组织学确诊为MSCC而出现神经症状并接受手术减压治疗的患者的数据。
本研究共纳入151例患者(平均年龄60.4岁,男性占57.6%)。5种最常见的转移瘤类型为肺癌、多发性骨髓瘤、肾癌、乳腺癌和前列腺癌。大多数患者患有放射抗拒性肿瘤(82.7%),且在就诊时原发部位仍有活动(67.5%)。从肿瘤诊断到脊髓压迫的中位时间为12个月,从发现脊髓压迫到死亡的中位时间为4个月。术前出现的症状包括运动无力(70.8%)、疼痛(70.1%)、感觉障碍(47.6%)以及肠道或膀胱功能障碍(31.1%)。估计术中失血量中位数为500 mL,平均住院时间为10.3天。约18%的患者有术后并发症,平均随访时间为7个月。术前和术后东部肿瘤协作组(ECOG)的体能状态分级平均分分别为3.2和2.4。随访时,58.3%的患者状态改善,31.5%无改善,10.0%的患者功能状态恶化。整个队列每年获得的平均QALY为0.55。前6个月获得的平均QALY为0.1,第1年为0.4。对于存活1 - 2年、2 - 3年、3 - 4年或4 - 5年的患者,获得的平均QALY分别为0.8、1.4、1.7和2.3。术前运动无力、肠道功能障碍、膀胱功能障碍和美国麻醉医师协会(ASA)分级被确定为与良好预后呈负相关的独立预测因素。
手术减压在最初6个月和第1年获得的平均QALY分别相当于完全健康状态下1.2个月和5个月的生命。这些发现表明,手术可能对预期寿命<6个月的患者也有益。